Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient

Glycobiology

Volumn 22, Issue 8, 2012, Pages 1140-1144

  Wada, Yoshinao ^a   Kadoya, Machiko ^a   Okamoto, Nobuhiko ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Apolipoprotein C III; ARCL2; Mass spectrometry; O glycan

Indexed keywords

APOLIPOPROTEIN C3;

ARTICLE; AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2; AUTOSOMAL RECESSIVE DISORDER; BLOOD SAMPLING; CONTROLLED STUDY; CUTIS LAXA; GLYCOSYLATION; HUMAN; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIALYLATION;

APOLIPOPROTEIN C-III; BLOTTING, WESTERN; CARBOHYDRATE METABOLISM, INBORN ERRORS; CASE-CONTROL STUDIES; CHILD; CUTIS LAXA; GLYCOSYLATION; HUMANS; ISOELECTRIC FOCUSING; MUCINS; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84863201152     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws086     Document Type: Article

References (38)

1. Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD. 1999. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J Lipid Res. 40:543-555. (Pubitemid 29116158)
2. Butler M, Quelhas D, Critchley AJ, Carchon H, Hebestreit HF, Hibbert RG, Vilarinho L, Teles E, Matthijs G, Schollen E, et al. 2003. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology. 13:601-622. (Pubitemid 37220439)
3. Catapano AL, Jackson RL, Gilliam EB, Gotto AM, Jr, Smith LC. 1978. Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing. J Lipid Res. 19:1047-1052. (Pubitemid 9059817)
4. Cruzado ID, Cockrill SL, McNeal CJ, Macfarlane RD. 1998. Characterization and quantitation of apolipoprotein B-100 by capillary electrophoresis. J Lipid Res. 39:205-217. (Pubitemid 28063556)
5. Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, Hirschberg CB, Tonetti M. 2002. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 110:131-135.
6. Faid V, Chirat F, Seta N, Foulquier F, Morelle W. 2007. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis. Proteomics. 7:1800-1813. (Pubitemid 46911000)
7. Foulquier F, Vasile E, Schollen E, Callewaert N, Raemaekers T, Quelhas D, Jaeken J, Mills P, Winchester B, Krieger M, et al. 2006. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc Natl Acad Sci USA. 103:3764-3769. (Pubitemid 43376629)
8. Freeze HH. 2006. Genetic defects in the human glycome. Nat Rev Genet. 7:537-551. (Pubitemid 43943571)
9. Freeze HH. 2007. Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond. Curr Mol Med. 7:389-96. (Pubitemid 46979703)
10. Gill DJ, Chia J, Senewiratne J, Bard F. 2010. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol. 189:843-858.
11. Grunewald S. 2007. Congenital disorders of glycosylation: Rapidly enlarging group of (neuro)metabolic disorders. Early Hum Dev. 83:825-830. (Pubitemid 350016677)
12. Haase R, Menke-Mollers I, Oette K. 1988. Analysis of human apolipoproteins C by isoelectric focusing in immobilized pH gradients. Electrophoresis. 9:569-575.
13. Hucthagowder V, Morava E, Kornak U, Lefeber DJ, Fischer B, Dimopoulou A, Aldinger A, Choi J, Davis EC, Abuelo DN, et al. 2009. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet. 18:2149-2165.
14. Hurtado-Lorenzo A, Skinner M, El Annan J, Futai M, Sun-Wada GH, Bourgoin S, Casanova J, Wildeman A, Bechoua S, Ausiello DA, et al. 2006. V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol. 8:124-136.
15. Jaeken J. 2010. Congenital disorders of glycosylation. Ann N Y Acad Sci. 1214:190-198.
16. Jaeken J, Matthijs G. 2001. Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet. 2:129-151. (Pubitemid 35265003)
17. Jaeken J, Matthijs G. 2007. Congenital disorders of glycosylation: A rapidly expanding disease family. Annu Rev Genomics Hum Genet. 8:261-278.
18. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189-197. (Pubitemid 351171402)
19. Kornak U, Reynders E, Dimopoulou A, van Reeuwijk J, Fischer B, Rajab A, Budde B, Nurnberg P, Foulquier F, Lefeber D, et al. 2008. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet. 40:32-34.
20. Lacey JM, Bergen HR, Magera MJ, Naylor S, O'Brien JF. 2001. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem. 47:513-518. (Pubitemid 32222467)
21. Leroy JG. 2006. Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects. Pediatr Res. 60:643-656. (Pubitemid 44789504)
22. Martinez-Duncker I, Dupre T, Piller V, Piller F, Candelier JJ, Trichet C, Tchernia G, Oriol R, Mollicone R. 2005. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood. 105:2671-2676. (Pubitemid 40446256)
23. Morava E, Wopereis S, Coucke P, Gillessen-Kaesbach G, Voit T, Smeitink J, Wevers R, Grunewald S. 2005. Defective protein glycosylation in patients with cutis laxa syndrome. Eur J Hum Genet. 13:414-421. (Pubitemid 40520931)
24. Pietrement C, Sun-Wada GH, Silva ND, McKee M, Marshansky V, Brown D, Futai M, Breton S. 2006. Distinct expression patterns of different subunit isoforms of the V-ATPase in the rat epididymis. Biol Reprod. 74:185-194. (Pubitemid 43068807)
25. Schjoldager KT, Vester-Christensen MB, Bennett EP, Levery SB, Schwientek T, Yin W, Blixt O, Clausen H. 2010. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: Possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids. J Biol Chem. 285:36293-36303.
26. Spaapen LJ, Bakker JA, van der Meer SB, Sijstermans HJ, Steet RA, Wevers RA, Jaeken J. 2005. Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder. J Inherit Metab Dis. 28:707-714. (Pubitemid 41349258)
27. Tajiri M, Kadoya M, Wada Y. 2009. Dissociation profile of protonated fucosyl glycopeptides and quantitation of fucosylation levels of glycoproteins by mass spectrometry. J Proteome Res. 8:688-693.
28. Tian E, Ten Hagen KG. 2009. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J. 26:325-334.
29. Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, Backstrom M, Costello CE, Hansson GC, Hiki Y, et al. 2010. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics. 9:719-727.
30. Wada Y, Gu J, Okamoto N, Inui K. 1994. Diagnosis of carbohydrate- deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. Biol Mass Spectrom. 23:108-109.
31. Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, Taniguchi N. 1992. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun. 189:832-836. (Pubitemid 23032449)
32. Wada Y, Tajiri M, Ohshima S. 2010. Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. J Proteome Res. 9:1367-1373.
33. Watkins LK, Bondarenko PV, Barbacci DC, Song S, Cockrill SL, Russell DH, Macfarlane RD. 1999. Fast C18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis. J Chromatogr A. 840:183-193. (Pubitemid 29199933)
34. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 40:161-169. (Pubitemid 351171403)
35. Wopereis S, Grunewald S, Huijben KM, Morava E, Mollicone R, van Engelen BG, Lefeber DJ, Wevers RA. 2007. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects. Clin Chem. 53:180-187. (Pubitemid 46338261)
36. Wopereis S, Grunewald S, Morava E, Penzien JM, Briones P, Garcia-Silva MT, Demacker PN, Huijben KM, Wevers RA. 2003. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin Chem. 49:1839-1845. (Pubitemid 37340318)
37. Wopereis S, Morava E, Grunewald S, Mills PB, Winchester BG, Clayton P, Coucke P, Huijben KM, Wevers RA. 2005. A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: The biochemical characteristics. Biochim Biophys Acta. 1741:156-164. (Pubitemid 40825001)
38. Zeevaert R, Foulquier F, Jaeken J, Matthijs G. 2008. Deficiencies in subunits of the conserved oligomeric Golgi (COG) complex define a novel group of congenital disorders of glycosylation. Mol Genet Metab. 93:15-21. (Pubitemid 350236002)